Pharmaceutical shake-up: Mallinckrodt and Endo to merge in blockbuster $6.7bn deal
Mallinckrodt plc and Endo, Inc. have announced a definitive agreement to merge in a stock and cash transaction that will create a global pharmaceutical powerhouse. ... Read More
Mallinckrodt shakes up pharma world with $925m deal – Therakos’ new era begins!
Mallinckrodt plc, a prominent global specialty pharmaceutical firm, has announced a major deal with CVC Capital Partners, one of the world's leading investment firms. Under ... Read More
Mallinckrodt to acquire Sucampo Pharmaceuticals in $1.2bn deal
In a strategic move to broaden its pharmaceutical offerings, UK-based Mallinckrodt has announced the acquisition of Sucampo Pharmaceuticals, including its commercial and developmental assets, for ... Read More